Water insecurity nearly quadruples odds of poor HIV outcomes, while hunger and partner violence compound risk in East Africa
Long-acting injectable treatment superior to daily pills for adolescents in African trial
Dolutegravir knocks down HIV faster than bictegravir
Islatravir plus ulonivirine shows promise for weekly oral HIV treatment
Once-weekly islatravir / lenacapavir combination pill maintains HIV viral suppression
Promise of monthly oral pill sparks renewed interest in post-exposure prophylaxis (PEP)
PEPFAR cuts close key population services and accelerate decline in children's HIV treatment
Over 40% of Ugandan mothers whose infants acquired HIV were only diagnosed while breastfeeding
Two more people cured of HIV after stem cell transplants, offering more clues to long-term remission
Fiji’s perfect HIV storm
New US HIV agreements leave civil society and key populations on the sidelines
Alternative first-line HIV regimen limits excess weight gain
Enhanced access to diagnostic screening improves care for advanced HIV
Returning to HIV care does not erase the effects of treatment interruption, studies show
CD4 counts fall much faster than they recover, increasing the harms of cycling in and out of care